Premiere Date: February 20, 2018
Expiration Date: July 20, 2019
This activity offers CE credits for:
1. Physicians (CME)
All other clinicians either will receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
To understand the role of stress in the manifestation of depressive symptoms.
At the end of this CE activity, participants should be able to:
• Describe the brain circuits associated with depressive symptom clusters
• Identify the multiple functions associated with reward systems (eg, anticipatory, consummatory)
• Explain how the frontal cortex affects cognition in depression
This continuing medical education activity is intended for psychiatrists, psychologists, primary care physicians, physician assistants, nurse practitioners, and other health care professionals who seek to improve their care for patients with mental health disorders.
CME Credit (Physicians):This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Outfitters, LLC, and Psychiatric Times. CME Outfitters, LLC, is accredited by the ACCME to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note to Nurse Practitioners and Physician Assistants: AANPCP and AAPA accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer-review process.
The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Serge Campeau, PhD, has no disclosures to report.
Bruce S. McEwen, PhD, (peer/content reviewer) has no disclosures to report.
Applicable Psychiatric Times staff and CME Outfitters staff have no disclosures to report.
UNLABELED USE DISCLOSURE
Faculty of this CME/CE activity may include discussion of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, and the faculty do not endorse the use of any product outside of the FDA-labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767)
1. Regier DA, Myers JK, Kramer M, et al. The NIMH Epidemiologic Catchment Area Program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry. 1984;41:934-941.
2. Maercker A, Brewin CR, Bryant RA, et al. Diagnosis and classification of disorders specifically associated with stress: proposals for ICD-11. World Psychiatry. 2013;12:198-206.
3. Casey P. Borderline between normal and pathological responses. In: Casey P, Strain JJ, eds. Trauma and Stressor Related Disorders. Washington, DC: American Psychiatric Press; 2016:1-22.
4. Cooper R. Avoiding false positives: zones of rarity, the threshold problem and the DSM clinical significant criteria. Can J Psychiatry. 2013;58:606-611.
5. Francis A. Whither DSM-V? Br J Psychiatry. 2009;195:391-392.
6. Kendall R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnosis. Am J Psychiatry. 2003;160:4-12.
7. Tyrer P. Limits to the phenomenological approach to the diagnosis of adjustment disorders. In: Casey, P Strain JJ, eds. Trauma and Stressor Related Disorders. Washington, DC: American Psychiatric Press; 2016:23-36.
8. Cowles MK, Nemeroff C. Depression as a systemic disease. In: Blumenfield M, Strain JJ, eds. Psychosomatic Medicine. Philadelphia: LLW Publishers; 2006:47-65.
9. Runeson BS, Beskow J, Waern M. The suicidal process in suicides among young people. Acta Psychiatr Scand. 1996;93:35-42.
10. Oxman TE, Barrett JE, Freeman DH, et al. Frequency and correlates of AD relates to cardiac surgery in older patients. Psychosomatics. 1994;35:557-568.
11. Strain JJ, Friedman M. Adjustment disorders. In: Dale DC, Federman DD, eds. ACP Medicine. New York: BC Decker; 2013:1-14.
12. Southwick SM, Davis LL, Aikins DE, et al. Neurobiological alterations associated with PTSD. In: Friedman MJ, Keane TM, Resik PA, eds. Handbook of PTSD, Science and Practice. New York: Guilford Press; 2007:166-189.
13. Wang X, Sundquist K, Hedelius A, et al. Leukocyte telomere length and depression, anxiety and stress and ADs in primary health care patients. BMC Psychiatry. 2017;17:148.
14. Wang X, Sundquist K, Rastkhani H, et al. Association of mitochondrial DNA in peripheral blood with depression, anxiety and stress—and adjustment disorders in primary care patients. Eur Neuropsychopharmacol. 2017;27:751-758.
15. McEwen BS, Rasgon NL. The brain and body on stress: allostatic load and mechanisms for depression and dementia. In: Strain JJ, Blumenfield M, eds. Depression as a Systemic Illness. New York and Oxford: Oxford University Press; 2018:14-36.